EDIT insider receives 43,567 shares in stock awards
By AlphaYouPublished Form 4
O'Neill Gilmore Neil
Reporting filer
O'Neill Gilmore Neil reported 43,567 shares of Common Stock in Editas Medicine, Inc. as grants or awards dated 2026-11-05. The Form 4 was disclosed on Nov 6, 2026. These were stock awards, not open-market purchases.
- Disclosed
- Nov 6, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | O'Neill Gilmore Neil | 2026-11-05 | A | Grant or award | 43567 | 0 | 286,756 | 1 day | Filed terms
|
Common Stock
- Owner
- O'Neill Gilmore Neil
- Date
- 2026-11-05
- Code
- A
- Action
- Grant or award
- Quantity
- 43567
- Price
- 0
- Following holdings
- 286,756
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-05
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- id: F1
- transaction Shares: 43567
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 286756
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- O'Neill Gilmore Neil: CEO, Director.
- F1: Reflects the vesting, upon the achievement of a specified research and development milestone, of a portion of a performance-based restricted stock unit award originally granted on March 2, 2024.
Original sources
Prepared automatically from public filing data. Report a correction.